Merck's PCSK9 pill holds 'significant advantage' with injectable-like cholesterol reductions: analysts
10th November 2025 Uncategorised 0Merck & Co.’s PCSK9-targeted pill achieved low-density lipoprotein cholesterol (LDL-C) reductions similar to those observed with existing injectables. More: Merck's PCSK9 pill holds 'significant advantage' with injectable-like cholesterol reductions: analysts Source: fierce
read more